Stock Events

Stock Events

R&S Group 

€18.98
31
+€0.08+0.42% 06:01 Today

Statistics

Day High
18.98
Day Low
18.98
52W High
36.38
52W Low
15.96
Volume
0
Avg. Volume
10
Mkt Cap
0
P/E Ratio
-
Dividend Yield
2.59%
Dividend
0.49

Upcoming

Dividends

2.59%Dividend Yield
May 26
€0.55
May 25
€0.54
Jun 24
€0.26
Jun 24
€0.26
Mar 13
€57.89
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

16SepExpected
Q4 2025
Next
0.91
1.25
1.58
1.91
Expected EPS
N/A
Actual EPS
N/A

Financials

14.01%Profit Margin
Profitable
2022
2023
2024
2025
444.79MRevenue
62.3MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow B8D.MU. It's not an investment recommendation.
Swiss Re
10
SREN.SW
Amazon
8
AMZN
Nestle SA
8
NESN.SW
UBS Group
8
UBSG.SW

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novartis
NOVN.SW
Mkt Cap237.14B
Novartis AG is a direct competitor in the pharmaceutical industry, offering a wide range of drugs that compete with R&S's product portfolio.
Pfizer
PFE
Mkt Cap162.16B
Pfizer Inc. is a global pharmaceutical company that competes with R&S in various therapeutic areas, including vaccines and biopharmaceuticals.
Merck
MRK
Mkt Cap370.89B
Merck & Co., Inc. competes in pharmaceuticals, particularly in the fields of oncology, vaccines, and infectious diseases, similar to R&S's focus areas.
Johnson & Johnson
JNJ
Mkt Cap663.28B
Johnson & Johnson is a diversified healthcare company that competes with R&S across several segments, including pharmaceuticals and medical devices.
Abbvie
ABBV
Mkt Cap453.19B
AbbVie Inc. competes with R&S in the biopharmaceutical field, particularly in immunology and oncology.
GSK
GSK
Mkt Cap99.96B
GlaxoSmithKline plc is a competitor in pharmaceuticals and vaccines, areas where R&S is also actively involved.
Astrazeneca
AZN
Mkt Cap252.33B
AstraZeneca PLC competes with R&S in the pharmaceutical sector, focusing on areas like oncology, cardiovascular, and respiratory diseases.
Bristol-Myers Squibb
BMY
Mkt Cap136.49B
Bristol-Myers Squibb Company competes in the biopharmaceutical field, particularly in cancer and immunology, which are key areas for R&S.
Sanofi
SNY
Mkt Cap106.01B
Sanofi competes with R&S in the healthcare sector, offering pharmaceuticals and vaccines in similar therapeutic areas.

About

R&S Group Holding AG is a manufacturer and provider of crucial electrical infrastructure products, with operations spanning the United Kingdom, Switzerland, Ireland, Italy, Poland, and the Middle East. Their product range includes various transformer types such as cast-resin units, oil-immersed distribution transformers, and instrument transformers. Additionally, they supply power transformers specifically designed for step-up/step-down operations, rectification, and furnace applications. Beyond manufacturing, the company offers extensive services including maintenance, modernization, and diagnostic solutions. These transformers are vital for numerous sectors, including power transmission and distribution networks, renewable energy generation (hydroelectric, wind, and solar photovoltaic systems), transportation and e-mobility, data centers, broader building and infrastructure developments, and harbor electrification projects. The company was formerly known as R&S International Holding AG before rebranding to R&S Group Holding AG in 2023, and its main office is located in Sissach, Switzerland.
Show more...
CEO
Eduardo Terzi
Employees
1328
Country
Australia
ISIN
CH1107979838
WKN
000A3C9E6

Listings

SW
CH
RSGN.SW
MU
DE
B8D.MU
F
DE
B8D.F

0 Comments

Share your thoughts

FAQ

What is R&S Group stock price today?▼
The current price of B8D.MU is €18.98 EUR — it has increased by +0.42% in the past 24 hours. Watch R&S Group stock price performance more closely on the chart.
What is R&S Group stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange R&S Group stocks are traded under the ticker B8D.MU.
Is R&S Group stock price growing?▼
B8D.MU stock has fallen by -2.47% compared to the previous week, the month change is a -10.05% fall, over the last year R&S Group has showed a -47.94% decrease.
When is the next R&S Group earnings date?▼
R&S Group is going to release the next earnings report on September 16, 2026.
What is R&S Group revenue for the last year?▼
R&S Group revenue for the last year amounts to 444.79M EUR.
What is R&S Group net income for the last year?▼
B8D.MU net income for the last year is 62.3M EUR.
Does R&S Group pay dividends?▼
Yes, B8D.MU dividends are paid annual. The last dividend per share was 0.55 EUR. As of today, Dividend Yield (FWD)% is 2.59%.
How many employees does R&S Group have?▼
As of September 09, 2026, the company has 1,328 employees.
In which sector is R&S Group located?▼
R&S Group operates in the Manufacturing sector.
When did R&S Group complete a stock split?▼
R&S Group has not had any recent stock splits.
Where is R&S Group headquartered?▼
R&S Group is headquartered in Sissach, Australia.